- https://www.novartis.com/stories/novartis-scientists-target-resistance-threat-malaria
Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.
- https://www.novartis.com/stories/organic-dealmaker-drug-discovery
New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.
- https://www.novartis.com/stories/open-resources-novartis-help-drive-innovation
With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.
- https://www.novartis.com/stories/physician-scientist-donald-ganem-takes-reins-infectious-disease
- https://www.novartis.com/stories/potential-weight-loss-treatment-takes-shape-help-from-patients
Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.
- https://www.novartis.com/stories/predictive-analytics-could-bring-medicines-patients-faster
Novartis researchers are using data to accelerate drug development.
- https://www.novartis.com/stories/tackling-health-toll-climate-change
- https://www.novartis.com/stories/bringing-real-change-people
An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.
- https://www.novartis.com/stories/staying-one-step-ahead-malaria-parasite
Thierry Diagana and his team are on a quest to discover new therapeutics for malaria. He believes malaria elimination is within our grasp, but emerging drug resistance could jeopardize the hard-fought progress.
- https://www.novartis.com/stories/cancer-cocktails-abl001-hitting-one-target-twice
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 38
- › Next page